March 2006
|Volume 18 Issue 3
Pulmonary arteriovenous fistulae, or malformations (PAVMs), are congenital or (rarely) acquired abnormal vascular connections between a pulmonary artery and a pulmonary vein. The fistula itself is typically a thin-walled aneurysmal vascular structure…
Brian Firth (Cordis Corporation): As you all probably know, Cordis, in its entirety, is a cardiovascular device company, and now a combination drug/device company. There are four major divisions: 1) Cordis Cardiology, 2) Cordis Endovascular, 3) Biose…
The Angio-Seal™ Hemostatic Puncture Closure Device (St. Jude Medical, St. Paul, Minnesota) uses a biodegradable anchor and resorbable collagen plug to achieve local hemostasis after cardiac catheterization with up to 8 Fr arterial sheaths. Many inves…
The medical history of a 59-year-old male, summarized by a selected frame of his most recent angiogram of the heart in a left anterior oblique projection (Figure 1), illustrates the contemporary device armamentarium to fight cardiac disease. Five yea…
Cardiogenic shock complicates 7% of acute myocardial infarctions (AMI) in patients presenting to hospitals, with a concomitant mortality rate of 70%.1 In the age of reperfusion therapy, significant improvement in reducing this adverse outcome for sho…
Dear Readers,
This issue of the Journal of Invasive Cardiology, which coincides with the Annual Scientific Sessions of the American College of Cardiology. Please be sure to visit our website for the informative case reports that are part of the Marc…
The extrinsic compression of the left main coronary artery (LMCA) secondary to pulmonary artery trunk (PA) dilatation is a relatively new syndrome that has been associated with severe pulmonary hypertension.1–5 It is mostly associated with acyanogen…
Stenting has reduced restenosis and the need for repeat intervention following percutaneous coronary intervention (PCI).1 However, lesions at the coronary bifurcation still present a challenge to the interventional cardiologist.2 To overcome the prob…
Stroke is a relatively rare but catastrophic complication of percutaneous coronary intervention (PCI), and is the cause of substantial morbidity and mortality rates. The incidence of stroke after PCI is reported to be 0.3 to 0.5%, which has not chang…
Percutaneous patent foramen ovale (PFO) closure is a treatment option for secondary prevention in patients with paradoxical embolism. Several procedural and postprocedural complications have been reported with the use of transcatheter techniques. Ear…